ELDAR Trademark

Trademark Overview

On Tuesday, March 24, 2026, a trademark application was filed for ELDAR with the United States Patent and Trademark Office. The USPTO has given the ELDAR trademark a serial number of 99721670. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 24, 2026. This trademark is owned by Sage Equity LLC. The ELDAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for assisting cancer patients in selecting optimal treatment options for their specific cancer diagnosis
eldar

General Information

Serial Number99721670
Word MarkELDAR
Filing DateTuesday, March 24, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesArtificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for assisting cancer patients in selecting optimal treatment options for their specific cancer diagnosis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 24, 2026
Primary Code042
First Use Anywhere DateSunday, March 15, 2026
First Use In Commerce DateSunday, March 15, 2026

Trademark Owner History

Party NameSage Equity LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78701
US

Trademark Events

Event DateEvent Description
Tuesday, March 24, 2026NEW APPLICATION ENTERED
Tuesday, March 24, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

eldar artificial cancer intelligence optimal treatment their diagnosis specific selecting options